One-stage Test

A. For cross-match

1. Wash the donor red blood cells to be tested at least

three times in isotonic saline.

2. Prepare 2 to 3% red blood cell (donor) suspension in

isotonic saline.

3. To an appropriately labeled test tube, add two drops

of recipient serum to be tested and two drops of donor

red blood cell suspension. Mix the contents thoroughly

but gently.

4. Immediately add two drops of Liquipap reagent.

5. Incubate at 37°C for 15 to 30 minutes.

6. Centrifuge at 1000 rpm for 2 minutes,

7. Gently resuspend and observe for agglutination and/

or hemolysis macroscopically and microscopically.

B. For antibody detection

1. Wash the reagent red blood cells to be tested at least

three times in isotonic saline.

2. Prepare 2 to 3% reagent red blood cell suspension to

be tested in isotonic saline.

3. To an appropriately labeled test tube, add two drops of

serum to be tested and two drops of reagent red blood

cell suspension under test.

4. Mix the contents and immediately add two drops of

Liquipap reagent .

5. Incubate at 37°C for 15 to 30 minutes.

6. Centrifuge at 1000 rpm for 2 minutes.

7. Gently resuspend and observe for agglutination and/

or hemolysis macroscopically and microscopically.

Alternatively, a two-stage test using Liquipap reagent

can also be performed as follows:

Two Stage Test

A. For cross-match:

1. Wash the donor red blood cells three times in isotonic

saline.

2. To an appropriately labeled test tube, add one drop of

washed packed cells (donor) and one drop of Liquipap

reagent.

3. Incubate the test tube at 37°C for 15 to 30 minutes.

4. Wash the Liquipap-treated donor red blood cells at

least three times with isotonic saline.

5. Prepare Liquipap treated 2 to 3% red blood cell

suspension of donor in isotonic saline.

6. To an appropriately labeled test tube, add one drop

of Liquipap treated 2 to 3% donor red blood cell

suspension.

7. Add two drops of recipient serum to be tested.

8. Mix well and incubate at 37°C for 30 minutes.

9. Centrifuge at 1000 rpm for 2 minutes.

10. Gently resuspend and observe for agglutination and/

or hemolysis macroscopically and microscopically.

B. For antibody detection:

1. Wash the reagent red blood cells to be tested three

times in isotonic saline.

2. To an appropriately labeled test tube, add one drop of

washed packed reagent red blood cells under test and

one drop of Liquipap reagent.

3. Incubate the test tube at 37°C for 15 to 30 minutes.

4. Wash the Liquipap treated reagent red blood cells

under test at least three times with isotonic saline.

5. Prepare Liquipap treated 2 to 3% reagent red blood

cell suspension under test in isotonic saline.

6. To an appropriately labeled test tube, add one drop

of Liquipap treated 2 to 3% reagent red blood cell

suspension under test.

7. Add two drops of serum to be tested.

8. Mix well and incubate at 37°C for 30 minutes.

9. Centrifuge at 1000 rpm for 2 minutes.

10. Gently resuspend and observe for agglutination and/

or hemolysis macroscopically and microscopically.

Interpretation of Results

Agglutination and/or hemolysis indicate an antibody

directed against the antigen present on the red blood cell

under test.

No agglutination and/or hemolysis indicate absence of

enzyme reactive antibodies directed against the antigen

present on the red blood cell under test.

Remarks

1. As undercentrifugation or over-centrifugation could

lead to erroneous results, it is recommended that each

Blood Banking (Immunohematology) 363

laboratory calibrate its own equipment and determine

the time required for achieving the desired results.

2. Erroneous results may also occur due to improper red

blood cell concentration, improper incubation time or

temperature while performing the test.

3. All enzyme preparations are subject to some loss of

potency, it is therefore, recommended to check the

reagent performance with known negative control

(neutral AB serum) and positive control (Coomb’s

control cells) on a regular basis.

4. The ability of papain to denature IgG molecule

renders the one-stage technique less sensitive though

it is a convenient method for use in cross-match

techniques.

5. Papain is not suited for the detection of Anti-M, N-SDuffy since the corresponding antigens are destroyed

during the proteolytic action of papain enzyme.

6. Liquipap reagent is a colorless to pale yellow clear

solution. Repeated exposure to elevated temperatures

may impart a dark color to the reagent. In such cases,

the reagent performance must be assessed closely

before use.

7. Usage of isotonic buffered saline while performing the

test ensures in maintaining the optimum pH of the

reaction milieu for antigen antibody reaction.

8. Alternatively, LISS (Low ionic strength solution) can

be used while performing the test. LISS lowers the

ionic concentration of the reaction milieu thereby

potentiating the rate of antibody uptake by the antigen

present on the red blood cell membrane.

9. It is recommended to run a control with each assay

series.

BLOOD TRANSFUSION

The procedures described earlier in this chapter are done

mainly for providing appropriate blood for transfusion, i.e.

the donor’s blood should be compatible in all ways with

the recipient’s blood.

Blood Donors

Most individuals can give blood without any ill effects, as

a matter of fact, without any symptoms at all. The donors

may be volunteers or paid donors. Blood transfusion

should always be a safe, harmless procedure, therefore,

the donors must be screened. Two basic principles govern

the transfusion services:

1. The donor should not be harmed in any way.

2. The recipient should be equally safe, i.e. the transfusion

should be absolutely safe for the recipient too.

Donor Screening

1. Identification: Identify the donor name, address and

other pertinent information. No donor should donate

twice in 3 months’ period. Preferably, the donors

should be between the ages 18 and 60 years.

2. History: The questions should be guided about the

present state of health; recent illness, if any; operations,

if any; if the donor has ever been transfused; (for

woman) if she ever gave birth to children who

developed jaundice shortly after birth; if they have

had malaria, jaundice, syphilis, tuberculosis; if they

have heart disease, diabetes, etc. Donors may give

wrong information on two accounts: (i) They want to

donate blood for want of money. (ii) They do not want

to donate blood for they are afraid of doing so. Hence,

a battery of tests to be done becomes necessary.

3. Physical examination:

Temperature reading, (exclude those having fever)

Blood pressure should be normal or only slightly

raised. Disqualify those who have moderate to

marked hypertension

Pulse should be normal without any irregularities

Auscultate the chest for any respiratory or cardiac

disorder. Discard individuals with respiratory/

cardiac problem

Pregnant women should not donate if they are

anemic

Finding of any venereal disease should outrightly

disqualify the donor until he receives adequate

treatment and gets rid of his problem.

4. Hemoglobin: The donors should not be anemic. It

is best to disqualify anybody having Hb < 12 g% but

keeping in view our health, dietetic, and economic

structure up to 10 g% can, however, be accepted,

weighing the urgency of the demand for blood. As

given in the hematology section specific gravity by

copper sulfate method is adequate for screening

donors’ Hb.

5. Malarial parasite: Malarial blood can cause transfusion

malaria if it is transfused. Screen all donors by making

thick and thin smears of their blood. In some chronic

malaria patient, no parasites may be seen on the

peripheral smear examination but a unit of their blood

would pass on enough parasites to the recipient.

6. Microfilaria: Screening for microfilaria should be done

both by making a wet, coverslip mount of a drop of

fresh blood (looking for the shipping movement of the

microfilaria) and also on the direct and stained films

used for searching malarial parasites. All microfilariaharboring donors are rejected.

364 Concise Book of Medical Laboratory Technology: Methods and Interpretations 7. Icteric index: This is the easiest method of measuring

and quantitating the amount of pigment (mostly

bilirubin) in the blood. Serum hepatitis is one of the

most dreaded complications of transfusion. If a person

has had jaundice during the last 5 years or is having it—

he should be disqualified as a donor. History might be

difficult to obtain and hence, liver function tests may

be necessary where there is even slightest of doubt.

The simplest and quickest to perform is icteric index,

a measurement of the level of bilirubin, expressed

in units based upon a comparison of the color of the

serum and the color of a standard dilute solution of

potassium dichromate. If the Icterus index is > 6 units,

the donor should not be allowed to donate.

 A major complication of transfusing blood from a

hepatitis B/C patient or carrier is the transmission

of the disease to the recipient. Now ELISA, ICT

techniques are available.

8. Serology: VDRL/Kahn’s tests should be performed

on blood of all donors. The blood positive for this test

may pass on live spirochetes to the recipient. Weighing

the need of blood even such a positive sample may

be transfused and the recipient given a course of

penicillin. In no case should any drug be put into

the transfusion bottle. It is known that Treponema

pallidum cannot survive for more than 48–72 hours

with the condition of storage of anticoagulated

blood in a refrigerator at 4oC. Within that time they

are all dead. Hence, blood which has been stored

as mentioned above cannot transmit syphilis since

there would be no viable organisms remaining. A

new syphilis patient’s blood may be VDRL/Kahn’s

negative even though his blood would contain the

spirochetes, hence, some believe in storing all blood

for 48–72 hours before allowing it to be transfused. It

is a good practice to indicate to the doctor who has

requisitioned the blood, date and time of procuring

that unit of blood.

9. Grouping and typing of donor: This has already been

dealt with at great length earlier in this chapter.

10. Antibody Screening: Ideally an indirect Coombs’ test

should be done on every donor to screen for atypical,

incomplete antibodies.

11. HIV/AIDS screening is a Must.

(Information regarding kits__refer to Serology chapter).

Drawing of Blood

1. Have the donor lie down.

2. Under aseptic conditions, do a venepuncture with a

fairly large needle on the donor set-15 or 16 gauge

needle, for gravity flow collection method. The bottle

is kept below the level of arm and has an airway so that

air may escape while the bottle gets filled with blood.

3. Where vacuum bottles are available a smaller gauge

needle can be used. Do not puncture such a bottle.

4. Plastic bags containing the preservative fluid are

already collapsed and hence, need no airway.

5. A unit of blood may mean different volumes at

different centers. A standard unit is 420 mL of blood

and 80 mL of ACD or CPD solution, i.e. a total 500 mL.

6. While the blood is being drawn swirl the bottle gently

to allow the ACD to act.

7. Flow of blood is usually hastened by: (i) having a blood

pressure cuff on the arm above the needle, inflated to

a pressure of 40–50 mm Hg and (ii) asking the patient

to gently flex the fingers or clench and unclench his fist

to assist the flow of the blood into the vein from which

it is being taken.

8. When the full amount of donation has been collected,

draw the needle from the bottle and put 5 to 10 mL

samples into 2 or 3 sterile, dry tubes, each with the

same number as that of the large blood transfusion

bottle.

9. Now the needle from the vein and the blood pressure

cuff can be removed.

10. Immediately apply pressure with cotton at the area,

preferably with the arm held straight up in an extended

position. Have the donor hold it for minimum 3 to 5

minutes.

11. Close the bottle immediately after sterilizing the

rubber cover.

12. Once closed do not open and enter the bottle until the

requisitioning doctor inserts the giving set. Be sure the

bottle is completely and correctly labeledwith number,

name, group, type, date, etc. Double check this.

13. Do not let the donor get up immediately. Let the

donor’s body adjust to the loss of this blood. Offering

a nourishing drink and snacks to the donor is indeed a

very good way of saying thanks to the donor. Encourage

him to drink little extra water for a few hours after the

donation.

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

TRIPASS XR تري باس

Kana Brax Laberax

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

CELEPHI 200 MG, Gélule

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more